Timing of anti-platelet effect after oral aspirin administration in patients with sympathetic excitement

Circulation Journal

Volumn 67, Issue 8, 2003, Pages 697-700

  Nishiyama, Atsushi ^a   Niikawa, Osamu ^a   Mohri, Hiroshi ^a   Tsushima, Motoo ^a  

^a KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Antiplatelet effect; Aspirin; Percutaneous coronary intervention; Sympathetic excitement

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; COLLAGEN; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ANTITHROMBOCYTIC ACTIVITY; ARTICLE; BALLOON DILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; HUMAN; MALE; SYMPATHETIC EXCITEMENT; SYMPATHETIC INNERVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0043095307     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.697     Document Type: Article

References (18)

1. Lewis HD Jr, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE 3rd, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: Results of a Veterans Administration Cooperative Study. N Engl J Med 1983; 309: 396-403.
2. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321: 129-135.
3. Antiplatelet Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
4. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1996; 94: 2341-2350.
5. Ishikawa K, Kimura A, Tanikawa T, Takenaka T, Hayashi T, Kanamasa K, on behalf of the Secondary Prevention Group. Moddification of treatment strategies over a period of 14 years has markedly reduced cardiac events among post-nyocardial infarction patients. Circ J 2002; 66: 881-885.
6. Benedek IH, Joshi AS, Pieniaszek HJ, King SY, Kornhauser DM. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol 1995; 35: 1181-1186.
7. Bochner F, Somogyi AA, Wilson KM. Bioinequivalence of four 100 mg oral aspirin formulations in healthy volunteers. Clin Pharmacokinet 1991; 21: 394-399.
8. Siebert DM, Bochner F. Determination of plasma aspirin and salicylic acid concentrations after low aspirin doses by high-performance liquid chromatography with post-column hydrolysis and fluorescence detection. J Chromatogr 1987; 420: 425-431.
9. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its revearsal. Nature 1962; 194: 927-935.
10. Barrett JE, DiMascio A. Comparative effects on anxiety of the 'minor tranquilizers' in 'high' and 'low' anxious student volunteers. Dis Nerv Syst 1966; 27: 483-486.
11. Nakano S, Ogawa N, Kawazu Y. Influence of neuroticism on oral absorption of diazepam. Clin Pharmacol Ther 1980; 27: 370-374.
12. Gomita Y, Katakoka Y, Ichimaru Y, Ueki S. Methamphetamine mortality to emotional stimuli administered in the form of affective communication. Life Sci 1983; 32: 941-947.
13. Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, et al. Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation. Circulation 1992; 86: 1859-1863.
14. Eto K, Ochiai M, Isshiki T, Takeshita S, Terakura M, Sato T, et al. Platelet aggregability under shear is enhanced in patients with unstable angina pectoris who developed acute myocardial infarction. Jpn Circ J 2001; 65: 279-282.
15. Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: Implications for the use of ASA clinically. Can J Cardiol 1995; 11: 221-227.
16. Kawasaki T, Ozeki Y, Igawa T, Kambayashi J. Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke 2000; 31: 591-595.
17. Gregorini L, Marco J, Fajadet J, Bernies M, Cassagneau B, Brunel P, et al. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures. J Am Coll Cardiol 1997; 29: 13-20.
18. McTavish D, Faulds D, Goa KL. Ticlopidine: An updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 1990; 40: 238-259.